Literature DB >> 7278087

[Increase of pulmonary vascular resistance and permeability due to the metabolism of free arachidonic acid (author's transl)].

W Seeger, H Wolf, G Stähler, H Neuhof, L Róka.   

Abstract

Release and metabolism of arachidonic acid are supposed to form the common final pathway of different stimuli on the pulmonary vascular endothelium. In a model of isolated, ventilated and perfused rabbit lungs we investigated the influence of increased availability of free arachidonic acid on pulmonary vascular resistance and permeability. Addition of arachidonic acid to the perfusion fluid or release of arachidonic acid by Ca-ionophore A 23187 regularly produces a characteristic biphasic increase of the pulmonary vascular resistance as well as a continuous increase in permeability, followed by pulmonary edema. Inhibition of cyclooxygenase by indomethacin prevents the augmentation of vascular resistance, the increase of vascular permeability however is enhanced. thus the raise in pulmonary vascular resistance can be ascribed to cyclooxygenase products, the increased pulmonary vascular permeability to lipoxygenase products of arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7278087     DOI: 10.1007/BF01695900

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  9 in total

Review 1.  [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)].

Authors:  O Oelz
Journal:  Ther Umsch       Date:  1979-10

2.  Leukotrienes: a new group of biologically active compounds.

Authors:  B Samuelsson; P Borgeat; S Hammarström; R C Murphy
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

3.  Differential actions of the prostaglandins on the pulmonary vascular bed.

Authors:  P J Kadowitz; E W Spannhake; J L Levin; A L Hyman
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

4.  Modification of the cardiovascular actions of prostaglandins by thromboxane B2.

Authors:  P A Kot; J C Rose; P W Ramwell; T M Fitzpatrick; M R Bloom; L S Friedman
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

5.  Vascular responses to arachidonic acid in the perfused canine lung.

Authors:  T C Wicks; J C Rose; M Johnson; P W Ramwell; P A Kot
Journal:  Circ Res       Date:  1976-03       Impact factor: 17.367

6.  Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187.

Authors:  W C Pickett; R L Jesse; P Cohen
Journal:  Biochim Biophys Acta       Date:  1976-01-18

7.  Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis.

Authors:  J F Burka; R J Flower
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

8.  Slow reacting substance of anaphylaxis, SRS-A; assignment of the stereochemistry.

Authors:  H R Morris; G W Taylor; J Rokach; Y Girard; P J Piper; J R Tippins; M N Samhoun
Journal:  Prostaglandins       Date:  1980-09

9.  Evidence that the effects of thrombin on arachidonate metabolism in cultured human endothelial cells are not mediated by a high affinity receptor.

Authors:  P Lollar; W G Owen
Journal:  J Biol Chem       Date:  1980-09-10       Impact factor: 5.157

  9 in total
  1 in total

1.  [The antioxidative chromane structure of alpha-tocopherol protects against the consequences of arachidonic acid release in the pulmonary vascular bed (author's transl)].

Authors:  H Wolf; W Seeger; G Stähler; H Neuhof; L Róka
Journal:  Klin Wochenschr       Date:  1981-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.